NEWS
RESOURCES
PODCAST
Donate
Subscribe
Search

Medication Subsidy (PBAC), Medications and Treatments, Disease Modifying Therapy, DMT, Pharmaceutical Benefits Advisory Committee, PBAC

MS Australia
registered charity

Let's connect

Newsletter subscribe
Facebook-f Twitter Linkedin-in Youtube Spotify

Participate in MS Research

Quick links

© 2024 Multiple Sclerosis Australia | ABN: 51 008 515 508 │Privacy Policy | Whistleblower Policy | Complaints Policy | Terms and Conditions
SUBSCRIBE
DONATE
CONTACT
Read More
Cladribine submission to PBAC – February 2018
Regulation of mobility scooters

Newsletter subscription

  • Enter your details

Cladribine (MAVENCLAD) for RRMS re-submission – March PBAC Review